The Centers for Disease Control and Prevention will discuss reports of a rare heart inflammation following doses of mRNA-based COVID-19 vaccines in an emergency meeting, it announced Thursday.
The emergency meeting, set to take place on June 18, will include updates on mRNA COVID-19 vaccine safety with a specific focus on rare reports of myocarditis and pericarditis, Scott Pauley of the CDC told The Daily Caller News Foundation. The risks and benefits of administering the mRNA COVID-19 vaccines to adolescents and young adults will also be discussed, according to the meeting’s agenda.
The announcement comes following a presentation to the Food and Drug Administration by Dr. Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office, confirming 226 cases of myocarditis/pericarditis in people under 30. These cases are more than twice what was expected under the FDA’s safety assessment for COVID-19 vaccines.Read More